martes, 14 de noviembre de 2017

Stomach Cancer Awareness Month (see related measures) | National Quality Measures Clearinghouse

Search | National Quality Measures Clearinghouse

nqmc



Health Awareness Topics: November 2017



  • MEASURE SUMMARY
    •  
  • NQMC:011171
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who receive curative oncological treatment who die within 30 days of treatment.

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:011279
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who undergo surgical resection in which longitudinal surgical margin is clear of tumour (i.e., negative surgical margin).

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:011163
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who have tumour node metastases (TNM) stage and treatment intent recorded at a multidisciplinary team (MDT) meeting prior to treatment.

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:011160
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who have a histological diagnosis made following initial endoscopy and biopsy.

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:011172
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who receive palliative oncological treatment who die within 30 days of treatment.

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:011166
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who die within 30 or 90 days of surgical resection for oesophageal or gastric cancer.

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:011169
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who undergo surgical resection in which circumferential and longitudinal surgical margin is clear of tumour (i.e., negative surgical margin).

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:010962
    •  
  • 2016 SEP

Upper gastrointestinal (UGI) endoscopy: percentage of endoscopy reports with accurate application of standardized disease-related terminology.

European Society of Gastrointestinal Endoscopy
  • MEASURE SUMMARY
    •  
  • NQMC:011161
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who undergo CT of the abdomen +/- chest +/- pelvis.

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:011167
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with gastric cancer who undergo surgical resection where greater than or equal to 15 lymph nodes are resected and pathologically examined.

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:011164
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who are referred to a dietitian within 4 weeks of diagnosis.

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:011170
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who undergo curative treatment.

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:010966
    •  
  • 2016 SEP

Upper gastrointestinal (UGI) endoscopy: percentage of patients in which management of precancerous conditions and lesions in the stomach (MAPS) guidelines are followed when applicable.

European Society of Gastrointestinal Endoscopy
  • MEASURE SUMMARY
    •  
  • NQMC:011162
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who are discussed at the multidisciplinary team (MDT) meeting before definitive treatment.

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:011165
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who receive neo-adjuvant chemotherapy who then undergo surgical resection.

NHS Scotland; Scottish Cancer Taskforce
  • MEASURE SUMMARY
    •  
  • NQMC:011168
    •  
  • 2015 JAN

Upper gastrointestinal (GI) cancer: proportion of patients undergoing surgical resection for oesophageal or gastric cancer who are discharged within 21 days of surgical procedure.

NHS Scotland; Scottish Cancer Taskforce
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)